Filing Details

Accession Number:
0000905148-23-001449
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-14 18:27:14
Reporting Period:
2023-11-10
Accepted Time:
2023-11-14 18:27:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604464 Atara Biotherapeutics Inc. ATRA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202785 Eric Dobmeier C/O Atara Biotherapeutics, Inc.
2380 Conejo Spectrum St, Suite 200
Thousand Oaks CA 91320
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-10 446,825 $0.23 563,325 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2235 to $0.2298. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.